Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure

J Antimicrob Chemother. 2006 Dec;58(6):1154-9. doi: 10.1093/jac/dkl412. Epub 2006 Oct 5.

Abstract

Objectives: The objective of this study was to determine the contribution of the CmeABC efflux pump to the emergence of fluoroquinolone (FQ)-resistant mutants in Campylobacter jejuni under various levels of selection pressure.

Methods: The frequency of emergence of ciprofloxacin-resistant mutants was measured in wild-type C. jejuni NCTC 11168 and its isogenic cmeB mutant and cmeR mutant (overexpressing cmeABC) using plates containing various concentrations of ciprofloxacin. Representative ciprofloxacin-resistant mutants were selected for gyrA sequence analysis and MIC determination. Accumulation of ciprofloxacin in Campylobacter cells was measured using spectrofluorometry.

Results: Mutation of cmeB drastically reduced the frequency of emergence of FQ-resistant mutants at 10x and 32x the MIC of ciprofloxacin, while the cmeR mutant displayed an approximately 17-fold increase in the frequency of emergence of the mutants at 32x the MIC when compared with the wild-type strain. Various point mutations occurred in gyrA in the FQ-resistant mutants selected at 5x and 10x the MIC, while the Thr-86-->Ile mutation was predominant in the mutants selected at 32x the MIC. The Thr-86-->Ile change conferred a high-level resistance to FQs, but other mutations only conferred an intermediate-level FQ resistance. In contrast, all types of gyrA mutations in the CmeABC-overexpressed background conferred high-level resistance to ciprofloxacin. Overexpression of cmeABC significantly reduced the amount of ciprofloxacin accumulated within bacterial cells.

Conclusions: CmeABC is not only important for maintaining high-level resistance to FQs but also contributes significantly to the emergence of FQ-resistant mutants. Inhibition of this efflux pump may prevent the emergence of clinically relevant FQ-resistant Campylobacter mutants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Substitution / genetics
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Biological Transport, Active / genetics
  • Campylobacter / drug effects*
  • Campylobacter / genetics*
  • Ciprofloxacin / metabolism
  • Ciprofloxacin / pharmacology
  • Cytoplasm / chemistry
  • DNA Gyrase / genetics
  • Drug Resistance, Bacterial / genetics*
  • Fluoroquinolones / metabolism
  • Fluoroquinolones / pharmacology*
  • Membrane Transport Proteins / metabolism*
  • Microbial Sensitivity Tests
  • Mutation, Missense
  • Point Mutation
  • Selection, Genetic
  • Sequence Analysis, DNA
  • Spectrometry, Fluorescence

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Membrane Transport Proteins
  • Ciprofloxacin
  • DNA Gyrase